Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Futrell N (1994). Connective tissue disease and sarcoidosis of the central nervous system. Curr Opin Neurol 7:201–208.PubMedGoogle Scholar
  2. 2.
    Minagar A, Hardjasudarma M, Kelley R (2002). Neurosarcoidosis. Neurology 59: 477.PubMedGoogle Scholar
  3. 3.
    Nowak DA, Widenka DC (2001). Neurosarcoidosis: A review of its intracranial manifestation. J Neurol 248:363–372.PubMedCrossRefGoogle Scholar
  4. 4.
    Randeva HS, Davison R, Chamoun V et al. (2002) Isolated neurosarcoidosis: A diagnostic enigma. Endocrine 17:241–248.PubMedCrossRefGoogle Scholar
  5. 5.
    Wiethölter H, Schmid E (1998). Neurosarkoidose. Akt. Neurologie 25:50–55.Google Scholar
  6. 6.
    Zajicek JP (2000). Neurosarcoidosis. Curr Opin Neurol 13: 23–325.CrossRefGoogle Scholar

Literatur

  1. 1.
    Coleman RM, Pollak CP, Weitzman ED (1980). Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol 8: 416–421.PubMedGoogle Scholar

Literatur

  1. 1.
    Jorgensen HS, Kammersgaard LP, Nakayama H, Raaschou HO, Larsen K, Hubbe P, Olsen TS (1999). Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study. Stroke 30(5):930–3.PubMedGoogle Scholar

Literatur

  1. 1.
    Alexander MP (1998). In the pursuit of proof of brain damage after whiplash injury. Neurology; 51:336–340PubMedGoogle Scholar
  2. 2.
    Castro WHM, Meyer SJ, Becker MER, Nentwig CG, Hein MF, Ercan BI, Thomann S, Wessels U, Du Chesne AE (2001). No stress — no whiplash? Prevalence of „whiplash“ symptoms following exposure to a placebo rerar-end collision. Int J Legal Med 114:316–322PubMedCrossRefGoogle Scholar
  3. 3.
    Chung YS, Han DH (2002). Vertebrobasilar dissection: A possible role of whiplash injury in its pathogenesis. Neurol Res 24:129–138PubMedGoogle Scholar
  4. 4.
    Ferrari R, Schrader H (2001). The late whiplash syndrome: a biopsychosocial approach. J Neurol Neurosurg Psychiatry; 70:722–726PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Schaumburg HH, Berger AR (1993) Human toxic neuropathy due to industrial agents. In: Dyck PJ, Thomas PK (eds) Peripheral Neuropathy. W. B. Saunders Company, Philadelphia, pp 1533–1548.Google Scholar

Literatur

  1. 1.
    Fry HJH (1989). Overuse syndromes in instrumental musicians. Sem Neurol 9: 136–145.CrossRefGoogle Scholar
  2. 2.
    Karp BI, Cole RA, Cohen LG et al. (1994). Longterm botulinum toxin treatment of focal hand dystonia. Neurology 44: 70–76.PubMedGoogle Scholar
  3. 3.
    Oppenheim H (1911). Über eine eigenartige Krampfkrankheit des kindlichen und jugendlichen Alters (dysbasia lordotica progressiva, dystonia musculorum deformans). Neurol ZBL 30: 1090–1107.Google Scholar
  4. 4.
    Oppenheim H (1913). Lehrbuch der Nervenkrankheiten. S. Karger, Berlin 6. Aufl. 902, 1681–1689.Google Scholar
  5. 5.
    Sheehy MP, Marsden CD (1982). Writers’ cramp-a focal dystonia. Brain 105: 461–480.PubMedGoogle Scholar

Literatur

  1. 1.
    Amato AA, Jackson CE, Kim JY, Worley KL (1997) Chronic relapsing brachial plexus neuropathy with persistent conduction block. Muscle Nerve 20, 1303–1307.PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Sepehrnia A (1998). Tumoren der Hirnnerven. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart New York 249–265.Google Scholar

Literatur

  1. 1.
    Nadol JB. Hearing loss. NEJM 1993; 329:1092–1102.PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Cass SP et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 1997; 106:182–189PubMedGoogle Scholar

Literatur

  1. 1.
    Ozmen M et al. (1991) Infantile neuroaxonal dystrophy: diagnosis by skin biopsy. Brain Dev 13:256–259.PubMedGoogle Scholar

Literatur

  1. 1.
    Besson G et al. (1991) Posterior choroidalartery infarct with homonymous horizontal sectoranopia. Cerebrovasc Dis 1:117–120.Google Scholar
  2. 2.
    Grochowicki M et al. (1991) Homonymous horizontal sectoranopia: report of four cases. Br J Ophthalmol 75:624–8.PubMedGoogle Scholar

Literatur

  1. 1.
    Burdt MA et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999; 42:899–909PubMedCrossRefGoogle Scholar
  2. 2.
    Kuroki M. et al. A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone]. Ryumachi 2000 Jun; 40:627–32PubMedGoogle Scholar
  3. 3.
    Maeda N. et al. Low-dose cyclosporin for multiple colonic ulcers associated with mixed connective tissue disease. Clin Rheumatol 1999; 18:410–3.)PubMedCrossRefGoogle Scholar
  4. 4.
    Mayr NA et al. Mixed connective tissue disease and radiation toxicity. A case report. Cancer 1997; 79:612–8PubMedCrossRefGoogle Scholar
  5. 5.
    Torley et al. A double blind, randomised, multicenter comparison of two dose of i.v. iloprost in the treatment of Raynaud’s phenomen secondary to connective tissue diseases. Ann Rheum Dis 1991; 50:800–804.)PubMedCrossRefGoogle Scholar
  6. 6.
    Ulmer A. Efficacy of pulsed immunglobulin therapy in MCTD. J Am Acad Dermatol 2002; 46:123–127PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Papas AS et al. (1998) Oral pilocarpin for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome. Adv Exp Med Biol 438:973–978.PubMedGoogle Scholar
  2. 2.
    Shiozawa S et al. (1998) Single-blinded controlled trial of low-dose IFN-alpha for the treatment of xerostomia in patients with Sjögrens syndrome. J Interferon Cytokine Res 18:255–262.PubMedCrossRefGoogle Scholar
  3. 3.
    Izumi M et al. (1998) Corticoid irrigation of parotid gland for treatment of xerostomia in patients with Sjögrens syndrome. Ann Rheum Dis; 57:464–469.PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Boolell M, Gepi-Attee S, Gingell JC, Allen MJ (1996) Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 78:257–261PubMedGoogle Scholar

Literatur

  1. 1.
    Barrow DL et al. (1985) Classification and treatment of spontaneus carotid cavernous sinus fistules. J Neurosurg 62:248–256.PubMedGoogle Scholar

Literatur

  1. 1.
    Jonsson R et al. Current issues in Sjogren’s syndrome. Oral Dis. 2002; 8:130–140PubMedCrossRefGoogle Scholar
  2. 2.
    Ogasawara H et al. Very low-dose cyclosporin treatment of steroid-resistant intersitial pneumonitis associated with Sjögren’s syndrome. Clin Rheumatol 1998; 17:160–162PubMedCrossRefGoogle Scholar
  3. 3.
    Pascual J et al. High-dose i.v. immunoglobulin for peripheral neuropathy associated with Sjögren’s syndrome. Neurology 1998; 51:650–651PubMedGoogle Scholar
  4. 4.
    Price EJ et al. A double-blind placebo-controlled trial of azathioprin in the treatment of primary Sjogren’s syndrome. J Rheumatol 1998; 25:896–899.PubMedGoogle Scholar
  5. 5.
    Schnabel A et al. Intravenous pulse cyclophosphamid in the treatment of interstitial lung disease due to collagen vascular disease. Arthritis Rheum 1998; 25:1215–1220Google Scholar

Literatur

  1. 1.
    Peet RM, Henriksen JD et al (1956) Thoracic outlet syndrome. Evaluation of therapeutic exercise program. Proc Mayo Clin 31: 281–287.PubMedGoogle Scholar

Literatur

  1. 1.
    Dubowitz V (1999). Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype. Eur J Paediatr Neurol 3(2): 49–51.PubMedGoogle Scholar

Literatur

  1. 1.
    Dina TS, Ching HAT (1996). Imaging of spinal tumors. In: Wilkins RH, Rengachary (Hrsg.) Neurosurgery. McGraw-Hill, New York 1757–1768.Google Scholar
  2. 2.
    Freitag HJ (1996). Spinale Tumoren und tumorähnliche Krankheiten. In: Sartor K (Hrsg.) Neuroradiologie. Thieme, Stuttgart.Google Scholar
  3. 3.
    Westphal M, Schlegel U (1998). Raumfordernde spinale Prozesse. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart. 291–305.Google Scholar
  4. 4.
    Portenoy RK, Galer BS, Salamon O et al. (1989) Identification of epidural neoplasm. Cancer 64:2207–2213.PubMedGoogle Scholar
  5. 5.
    Fehlings MG, Rao SC (2000). Spinal cord and spinal column tumors. In: Bernstein M, Berger MS (eds.) Neuro-Oncology. The Essentials. Thieme, New York. 445–464.Google Scholar
  6. 6.
    Maranzano E, Latini P Checcaglini F et al. (1991) Radiation therapy in metastatic spinal cord compression: a prospective analysis in 105 consecutive patients. Cancer 67:1311–1317.PubMedGoogle Scholar
  7. 7.
    Helweg-Larsen S, Rasmusson B, Sorensen PS (1990). Recovery of gait after radiotherapy in paralytic patients with metastatic epidural spinal cord compression. Neurology 40:1234–1236.PubMedGoogle Scholar
  8. 8.
    Posner JB (1995). Neurologic complications of cancer. FA Davis Company, Philadelphia.Google Scholar
  9. 9.
    DeVita VT, Hellman S, Rosenberg SA (1997). Cancer. Principles & Practice of Oncology. Lippincott-Raven, Philadelphia.Google Scholar

Literatur

  1. 1.
    Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB, for the Veteran Affairs status epilepticus study group (1998). A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339:792–798.PubMedCrossRefGoogle Scholar
  2. 2.
    Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ (1998). Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 39:18–26.PubMedCrossRefGoogle Scholar
  3. 3.
    Venkataraman V, Wheless JW (1999). Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 35:47–53.CrossRefGoogle Scholar

Literatur

  1. 1.
    Barclay CL, Lang AE (1997). Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 62: 353–6.CrossRefGoogle Scholar
  2. 2.
    Engel PA (1996) Treatment of progressive supranuclear palsy with amitriptyline: therapeutic and toxic effects. J Am Geriatr Soc 44: 1072–4.PubMedGoogle Scholar
  3. 3.
    Litvan I, Agid Y, Calne D et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewsky syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9.PubMedGoogle Scholar

Literatur

  1. 1.
    Berlit P. Pathogenese und Klinik der Strahlenfolgen am zentralen Nervensystem unter besonderer Berücksichtigung der Strahlenmyelopathie. Nervenheilkunde 1989; 8:86–88.Google Scholar
  2. 2.
    Komachi H et al. Radiation myelopathy: a clinicopathological study with special reference to correlation between MRI findings and neuropathology. J Neurol Sci. 1995; 132:228–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Glantz MJ. et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994; 44:2020–7.PubMedGoogle Scholar
  4. 4.
    Angibaud G, Ducasse JL, Baille G, Clanet M. Potential value of hyperbaric oxygenation in the treatment of post-radiation myelopathies. Rev Neurol 1995; 151:661–6.PubMedGoogle Scholar

Literatur

  1. 1.
    Berlit P (1989) Pathogenese und Klinik der Strahlenfolgen am zentralen Nervensystem unter besonderer Berücksichtigung der Strahlenmyelopathie. Nervenheilkunde 8:86–88.Google Scholar

Literatur

  1. 1.
    Lewanski CR et al. Lhermitte’s sign following head and neck radiotherapy. Clin Oncol (R Coll Radiol) 2000; 12:98–103.Google Scholar

Literatur

  1. 1.
    Schlegel U et al (2004). Neuroonkologie. Thieme, Stuttgart New York.Google Scholar

Literatur

  1. 1.
    Taghian A, Ramsay J, Allalunis-Turner J et al. (1993) Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25:243–249.PubMedGoogle Scholar
  2. 2.
    Engenhardt-Cabiillic R, Wannenmacher M (1998). Strahlentherapie. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart New York 147–158.Google Scholar
  3. 3.
    Walker MD, Green SB, Byar DP et al. (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329.PubMedGoogle Scholar
  4. 4.
    Schlegel U, Schmidt-Wolf IG, Deckert M (2000). Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 181:1–12.PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    International Subarachnoid Aneurysm Trial (ISAT) (2002). Lancet 360:1267–1274Google Scholar

Literatur

  1. 1.
    Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tomson T (1999). Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353:888–893.PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Lowe JB, Novak CB, Mackinnon SE (2001) Current approach to cubital tunnel syndrome. Neurosurg Clin N Am 12: 267–284.PubMedGoogle Scholar
  2. 2.
    Mowlavi A, Andrews K, Lille S, Verhulst S, Zook EG, Milner S (2000) The management of cubital tunnel syndrome: a meta-analysis of clinical studies. Plast Reconstr Surg 106: 327–334.PubMedGoogle Scholar
  3. 3.
    Mumenthaler M, Schliack H (1987) Läsionen peripherer Nerven. Thieme, Stuttgart New York.Google Scholar

Literatur

  1. 1.
    Tfelt-Hansen P (1998) Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on numbers needed to treat. Cephalalgia 18:532–538PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Dyck PJ (1993) Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK (eds) Peripheral Neuropathy. W. B. Saunders Company, Philadelphia, London, pp 1065–1093.Google Scholar

Literatur

  1. 1.
    Westphal M, Schlegel U (1998). Raumfordernde spinale Prozesse. In Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart New York 291–305.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations